Elsa Shapiro, Ph.D., is Professor of Pediatrics and Neurology in the Division of Pediatric Behavioral Neuroscience at the University of Minnesota. She is retired, but remains a part-time faculty member. She now has a consulting practice to provide assistance to the pharmaceutical industry in the use of neurocognitive and neurobehavioral endpoints in clinical trials and natural history studies with rare diseases. Elsa Shapiro completed her PhD in Psychology from the University of Minnesota and took her internship and post-doctoral training at National Children’s Medical Center in Washington DC. 

Dr. Shapiro is known for research in neurobehavioral and neuroimaging manifestations of genetic neurodegenerative disorders. She developed methods of longitudinal assessment of neurocognitive functions, delineated the neurocognitive phenotypes of several genetic disorders, studied the relationships between quantitative neuroimaging and neuropsychology in treated and untreated children, and examined the characteristics of dementia in children with neurodegenerative disease. She has more than 100 peer-reviewed publications and invited chapters. Recently, she was the co-Principal Investigator of the NIH-supported Lysosomal Disease Network, and Principal Investigator of Longitudinal Studies of Brain Structure and Function in the Mucopolysaccharidoses until 2014. She was also Co-Principal Investigator of a natural history study of MPS III.

Representative Publications:

Long-Term Safety and Clinical Outcomes of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Type A

A Multicenter Open-Label Extension Study of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Type A

The Natural History of Neurocognition in MPS Disorders: A Review

Response to: Investigating the Neurobehavioral Symptoms of Neuronopathic Hunter Syndrome

Share

Discuss in Social Wall

Share to rareTeam

Bookmark